86. 肺動脈性肺高血圧症 [臨床試験数:1,083,薬物数:667(DrugBank:122),標的遺伝子数:98,標的パスウェイ数:185

Searched query = "Pulmonary arterial hypertension", "PAH", "IPAH", "HPAH", "Eisenmenger syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03617458August 23, 20182/5/2018Interventions Against Insulin Resistance in Pulmonary Arterial HypertensionInterventions Against Insulin Resistance in Pulmonary Arterial HypertensionPulmonary Artery HypertensionDrug: Metformin;Drug: Placebo;Device: mHealth Intervention;Device: Usual CareVanderbilt University Medical CenterMayo Clinic;The Cleveland ClinicRecruiting18 YearsN/AAll130Phase 2United States
2NCT01352026May 201110/5/2011Evaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial HypertensionDrug: MetforminNantes University HospitalNULLWithdrawn18 Years80 YearsBoth0Phase 2France